Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities
Guardado en:
Autores principales: | Vishal Vyas, Pier Lambiase |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fceb868690e74cf5af21f3e5987188d3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Maximising Opportunities Post Coronavirus Disease 2019: Time to Embrace a New Era of Atrial Fibrillation Research
por: Pier D Lambiase
Publicado: (2021) -
Obesity and Atrial Fibrillation: Epidemiology, Pathogenesis and Effect of Weight Loss
por: Ahmed M Al-Kaisey, et al.
Publicado: (2021) -
Reconceptualising Atrial Fibrillation Using Renewal Theory: A Novel Approach to the Assessment of Atrial Fibrillation Dynamics
por: Jing Xian Quah, et al.
Publicado: (2021) -
Atrial Myopathy Underlying Atrial Fibrillation
por: Harold Rivner, et al.
Publicado: (2020) -
Atrial Fibrillation and Oral Health
por: Amaar Hassan, et al.
Publicado: (2021)